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Abstract
Multimarker Transmission/Disequilibrium Tests (TDTs) are very robust association tests to population admixture and
structure which may be used to identify susceptibility loci in genome-wide association studies. Multimarker TDTs using
several markers may increase power by capturing high-degree associations. However, there is also a risk of spurious
associations and power reduction due to the increase in degrees of freedom. In this study we show that associations found
by tests built on simple null hypotheses are highly reproducible in a second independent data set regardless the number of
markers. As a test exhibiting this feature to its maximum, we introduce the multimarker 2-Groups TDT (mTDT2G), a test
which under the hypothesis of no linkage, asymptotically follows a x2 distribution with 1 degree of freedom regardless the
number of markers. The statistic requires the division of parental haplotypes into two groups: disease susceptibility and
disease protective haplotype groups. We assessed the test behavior by performing an extensive simulation study as well as
a real-data study using several data sets of two complex diseases. We show that mTDT2G test is highly efficient and it
achieves the highest power among all the tests used, even when the null hypothesis is tested in a second independent data
set. Therefore, mTDT2G turns out to be a very promising multimarker TDT to perform genome-wide searches for disease
susceptibility loci that may be used as a preprocessing step in the construction of more accurate genetic models to predict
individual susceptibility to complex diseases.
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Introduction
Current commercially-available genotyping technologies for
identifying Single-Nucleotide Polymorphisms (SNPs) are able to
scan a few hundred thousands of these binary markers in a single
chip array. With such arrays, in-silico genome-wide single nucleotide
polymorphisms (SNP) filtering can be performed as a preprocessing
step, before more expensive, molecular-based experimentation, as
a way to reduce costs when searching for loci that may be
associated to a disease. The most common way of filtering is by
performing control-case association studies. However, they are
known to inflate type-I errors due to population stratification [1,2].
An alternative, which is robust to population stratification, is the
Transmission/Disequilibrium Test (TDT), a single marker and
biallelic test able to detect genetic linkage in the presence of
genetic association. Different multimarker generalizations of TDT,
such as mTDT [3,4], enhance the test by detecting marker
interaction, i.e., when a single marker is independent of the trait,
but there is association when more than one marker are
considered together. This conditional dependence may point out
to gene-gene interactions (epistasis), or just to a disease
susceptibility gene whose disease allele needs more than one
marker to be tagged. TDT is also enhanced by multimarker TDTs
when there are no sequenced markers that actually belong to the
disease susceptibility locus, but which are in strong linkage
disequilibrium (LD) with it [5,6].
Let us assume that data consist of M nuclear families with one
affected offspring, and that L SNPs are genotyped for each family
member. As an example, for L~2, and assuming biallelic SNPs,
there will be only k~4 different haplotypes: AB,Ab,aB,ab: Let us
consider a sample S composed of all transmitted and nontrans-
mitted haplotypes whenever parents are heterozygous. Let n be the
sample size, i.e. the number of haplotypes from all heterozygote
parents. Thus, the subsample ST of transmitted haplotypes has
n=2 haplotypes, as well as the subsample SU of nontransmitted
haplotypes. If all the parents were heterozygous for the genotyped
loci, n~4M would hold.
In nuclear families with one affected child, there must be a
difference between frequencies of nontransmitted and transmitted
haplotypes if they are directly associated with the disease, or in
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association with a disease, the most-frequently transmitted
haplotypes are disease susceptibility haplotypes. Multimarker
TDTs rely on this idea in order to detect linkage in presence of
association between a haplotype and a disease susceptibility locus.
In contrast to monomarker TDTs, they are more powerful as they
are able to detect interaction effects between markers. However,
they have an important issue of sample reproducibility. Sample
reproducibility refers to the extent to which power reached by a
test does not change when the same null hypothesis built using the
first data set is used in a second independent data set from the
same population. Moreover, the lack of sample reproducibility of
multimarker TDTs increases with the number of markers. The
reason of this discouraging behavior is because most of them are
poorly specific and simultaneously check effects of all the
haplotypes found in the data set. For such a generic alternative
hypothesis, degrees of freedom (df) strongly increase and very large
data sets are required to find consistent associations [7]. Therefore,
even if power should increase with haplotype length, the
incremental problem of sparse data affects consistency of both
power and locus specificity. In practice these tests become
inaccurate, except when using one or a couple of SNPs, and their
results hardly reproducible in different data sets. Considering the
alternative hypothesis as a linkage model composed by sets of
haplotypes under the rules of an specific multimarker measure, the
number of markers tested together affects model complexity.
Therefore, for the same statistic, the higher the number of
markers, the larger the data set has to be to detect true
associations, i.e. associations in the population, which therefore
should also be found in a different data set from the same
population. In the very other extreme of only one marker, there
will be only two different alleles and very small data sets may be
enough for accurate estimators of population models, models
which will also replicate in a different data set.
As abovementioned, one example of a multimarker TDT is
mTDT [3,4], a straightforward extension of TDT to be used with
haplotypes defined as:
mTDT~
k{1
k
X k
i~1
(niT{niU)
2
niTzniU
,
with k being the number of different alleles/haplotypes and niT,
niU being respectively the number of times an allele/haplotype i is
transmitted and nontransmitted, considering only heterozygous
parental genotypes. The measure has a limiting x2 with k{1
(x2
k{1) df under no linkage [8]. mTDT was modified by mTDTS
[9], a score method to guarantee that it asymptotically follows an
exact x2
k{1 under the null hypothesis of no linkage. Other more
recent alternatives are: mTDTE [10], based upon the concept of
entropy, whose null distribution is also x2
k{1 but which reaches
lower power than the classic mTDT and mTDTS under a wide
range of genetic scenearios [6], and mTDTP, a test which weighs
haplotypes by their frequencies and which outperforms mTDT
and mTDTS under the ‘common disease-common variant’
(CDCD) hypothesis [6].
Some solutions to reduce df have been proposed, such as
grouping haplotypes or using measures based on haplotype
similarities [2,7,11,12]. Sometimes, criteria used to select groups
may rely on strong assumptions that reduce the power whenever
they do not hold. This is the case for ET{TDT, a group-based
test that uses a haplotype evolutionary relationship [13] that first
requires estimation of a cladogram, which assumes no recurrent
disease mutations and no recombination or gene conversion.
Perhaps the simplest group-based multimarker TDT is mTDT1
[8,14], which uses the maximum of the biallelic TDT statistics
computed for each haplotype versus all others combined but does
not follow a x2 distribution under the null except for haplotypes of
only one marker, so that the more markers are used, the larger the
false positive rate. The Bonferroni correction is too conservative
and other alternatives that do not require unaffordable simulation-
based analysis [15] only provide lower and upper bounds to
calculate power and type-I errors respectively but are not easily
generalized to be used in genome-wide association studies (GWAS)
in which power and type-I errors are the two extremes (0 and 0:5
respectively) of an increasing recombination fraction with distance
to a disease susceptibility or protective locus. Some similarity-
based tests rely also in strong assumptions which reduce the power
in a general basis [6]. For example, the Length Contrast Test
(mTDTLC) [5], and the Signed Rank Test (mTDTSR) based on
mTDTLC that uses a Wilcoxon score [5], assume that there must
be less variation within transmitted haplotypes to affected offspring
than within nontransmitted haplotypes [2]. Moreover, the
attempts to reduce df yielding to these similarity measures
translated as well into an increase in computational complexity.
Therefore, the measures are computed by pairwise comparisons
between individuals, so that their computational complexity is
quadratic on the number of founders, in contrast with most TDT
measures, which use sample frequencies and are linear for the
number of individuals. For current data sets, like those used in this
work which contained over two thousand individuals, this
constitutes an important burden when used for genome-wide
searching. If the distribution under the null hypothesis is unknown,
and has to be estimated using permutations, as it is the case with
most similarity and group-based tests [2,5,12,16,17], the compu-
tational time can also increase significantly. Even if computational
complexity is linear to the number of permutations, the test is not a
practical choice for use in genome-wide association searches.
After showing how state-of-the-art multimarker TDTs reduce
sample reproducibility with the increase in the number of markers,
our goal was to define a highly powerful, locus specific and
computationally feasible multimarker TDT for performing
genome-wide association searches which is also highly reproduc-
ible when a second data set from the same population is used. We
conjectured that reducing df to a minimum regardless to the
number of markers should help to reach this goal, and we defined
mTDT2G, a multimarker TDT that is x2
1 under the null. To
achieve this reduction in df, haplotypes are categorized into only
two groups: one group represents the disease susceptibility
haplotypes and is composed of those haplotypes whose transmis-
sion count is higher than their non-transmission count, while the
other group represents the protective haplotypes and is composed
of those haplotypes that are more frequently nontransmitted. The
idea of grouping haplotypes in low and high risk ones was already
suggested [14] but no alternative solution was provided to
supersede the risk of inflated type-I errors if ad-hoc grouping
were performed. In this work we go ahead with this idea and
propose a simple alternative approach to ad-hoc grouping, called
holdout, to avoid the common problem of multiple testing (sample
overfitting) in group-based association tests which would yield to
inflated type-I errors when more than one marker is used at a time
and which becomes very severe for haplotypes with a few markers.
Therefore our approach guarantees the statistic is x2
1 under the
null. Under this approach, we randomly divide the data set into
two halves, and use one half to choose the two haplotype groups
and the other one to infer statistical significance. More complex
multisampling approaches such as cross-validation, which divides
the data set into at least two folds and obtains a central statistic
Sample Reproducibility in Multimarker TDTs
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e29613from the measure obtained by each fold, could be used. However,
power may be inflated because dependence between data subsets
makes the statistic not to follow a chi square under the null
hypothesis of no linkage. We performed simulations in order to
compare power, locus specificity and sample reproducibility of
mTDT2G with several state-of-the-art multimarker TDTs. We also
tested mTDT2G using real data sets comprising family trios with
offspring having a complex disease. We showed that mTDT2G can
be used to narrow down regions known to contain some
susceptibility loci to multiple sclerosis (MS) and Crohn diseases
that are either too wide or undetectable by other multimarker
TDTs. We also used the holdout approach with mTDT1, which
we have called mTDT1{h, instead of using corrections which tend
to over-correct results, such as the Bonferroni correction [18], or
which become unaffordable for genome wide scan such as
permutation-based corrections [12].
Results
The 2-groups multimarker TDT
As abovementioned, mTDT2G reduces df by further relaxing
the small assumptions made in the definition of mTDT or
mTDTS. Thus, the test does not assume any fixed number of
different haplotypes within the population, as there may always be
haplotypes in a population that do not appear in the data set used.
It only considers two groups: group g1, or high-risk group, with all
the haplotypes that are most often transmitted to affected
individuals, versus group g2, or low-risk group, with all the
haplotypes that are most often non transmitted to affected
individuals.
haplotype hi[
g1 if niTwniU
g2 if niTvniU,
 
Those haplotypes with the same number of transmitted and
nontransmitted counts are not included in any group. Moreover,
once the groups are defined, and in order to compute the statistic
for a data set, those parental genotypes whose two haplotypes
belong to the same group are considered homozygous and are
disregarded as all the haplotypes in the same group are collapsed.
Except for only one biallelic marker where there is only one
model (two haplotypes), there is always a risk of sample overfitting,
i.e. inflated power, which increases with the number of markers as
the number of different models also increases. Therefore, there are
2k{1{1 different ways of dividing haplotypes between two
disjoint and non-empty groups, with k being the number of
different haplotypes in the sample. If the same data set were used
and no correction were performed, the problem of overfitting
would arise: the statistic would be overfitted to that data set, with
much larger values than when a different data set were used to
infer the groups. Therefore, it would barely be reproducible in a
different data set from the same population, with lack of sample
reproducibility increasing with the number of markers. If a
classical linear multiple testing correction were performed such as
the Bonferroni correction, power would strongly decrease, as true
association results would be over-corrected [18].
Our solution applies holdout, a very simple multisampling
approach: the data set with parental genotypes is divided into two,
by default equally sized, data subsets, so that one (the training data
set) is used to learn the model and the other (the test data set) to
compute the statistic. Therefore, the training data set is used to
define the groups, i.e. to assign each haplotype inside the data set
to one of the 2 groups, and the counts to compute the statistic are
obtained by using only ng genotypes of the test data set: those
heterozygous parental genotypes with one haplotype in each
group. To assign a haplotype in the test data set to a group, the
following rule is used:
haplotype hi[
g1 if dmin(hi,g1)vdmin(hi,g2)
g2 if dmin(hi,g2)vdmin(hi,g1),
 
ð1Þ
with dmin(hi,gx),x1,2 being defined as the distance between hi and
the haplotype in gx most similar to hi. As similarity measure we
chose the length similarity measure [5,12,19], which equals the
largest number of consecutive markers with matching alleles and
which is also used in mTDTLC and mTDTSR [5].
The k|k table with haplotype transmissions (one column and
row per haplotype), is reduced by mTDT2G to only two cells in a
2|2 table, with rows representing transmitted group counts and
columns representing non transmitted group counts (see Table 1).
The first row, second column contains ng1g2, the number of times a
heterozygous parent from the test data set with one haplotype in
each group transmits the haplotype belonging to g1 to their
offspring and does not transmit the one belonging to g2: In an
equivalent way, the first column, second row contains ng2g1, the
number of times a heterozygous parent from the test data set with
one haplotype in each group transmits the haplotype belonging to
g2 to their offspring and does not transmit the one belonging to g1:
Therefore, counts for each used cell, defined by whether g1 is
transmitted (T) and g2 not (U) or the other way around, are
computed by summing up the counts of all the genotypes with one
haplotype in each group and the same transmission status. Hence,
ng1g2 is computed as:
ng1g2~
X
hi[g1,hj[g2
nij, ð2Þ
with nij being the number of parents with genotype (hi,hj)
transmitting haplotype hi to their offspring. The other count ng2g1
is computed in an equivalent manner.
The statistic is defined as:
mTDT2G~
(ng1g2{ng2g1)
2
ng
:
mTDT2G checks differences in transmissions of group g1 versus
group g2, so that it is a McNemar test (x2
1) equivalent to the single
locus biallelic TDT whenever haplotypes are collapsed into groups
and counts were computed by using a different data set. Text S1
shows that mTDT2G is x2
1 under the null hypothesis of no linkage.
Table 1. The 2|2 table used by mTDT2G.
Nontransmitted group
Transmitted group g1 g2 Total
g1 - ng1g2 ng1g2
g2 ng2g1 - ng2g1
Total ng2g1 ng1g2 ng
Only those ng parental genotypes with one haplotype in each group are used
by mTDT2G: The counts refer to the number of times haplotypes in one group
are transmitted by heterozygous parents to their affected offspring.
doi:10.1371/journal.pone.0029613.t001
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samedatasetfromwhichthestatisticiscomputed,mTDT2G defaults
to the usual formula of simple TDT in the case of only one biallelic
marker.
Tables 2, 3 and 4 show how to compute mTDT2G in a simple
example with only two biallelic markers. The data set is first divided
intotwo equal-size data subsets (seeTable 2).Table 3 left grid shows
a k|k table (k~4) with counts for the training data subset, i.e. the
one used to make up groups, using rows to represent transmitted
haplotypes and columns to represent nontransmitted haplotypes. As
it is shown, the only haplotype in the training data set which is more
often non transmitted (56 times) than transmitted (40 times) is AB:
Therefore, group g2 contains only this haplotype. Haplotypes Ab
and aB have transmission counts smaller than non-transmission
counts so that they make up group g1: As haplotype ab is
transmitted as many times as it is non-transmitted, it is not assigned
to any group. Table 3 right grid shows a k|k table (k~4) with
counts from the test data subset, i.e. the one used to compute the
statistic. These counts are used to fill two cells in Table 4, the only
two cells in a 2|2 table of group counts used by mTDT2G: To
obtain the counts for Table 4 from Table 3 right grid (test data
subset) the haplotypes are first assigned to eachgroup definedby the
training data set. Following Equation 1 haplotype ab is assigned to
the group with the most similar haplotype. As the two most similar
haplotypes belongs to group g1, ab is also assigned to this group.
Note that mTDT2G collapses all haplotypes in each group.
Therefore, only those individuals with one haplotype at each
group (hi[g1=hj[g2) are considered.
Implementation
The test has been implemented in 2G, an open source (GPL 2
license) GNU c++ software which can be download from the
supplementary website (http://bios.ugr.es/2G).
Results from simulations
We have performed four sets of simulation studies. The purpose
of the first set of simulations was to test sample reproducibility in
some state-of-the-art methods. The purpose of the second set of
simulations was to show mTDT2G is robust to population
stratification and admixture. The purpose of the third set of
simulations was to test sample reproducibility of mTDT2G and
other tests when used under the holdout approach (see Section
Materials and Methods for a detailed explanation about the
simulation studies). Finally, the four set of simulations was used to
show robustness of mTDT2G to different proportions of missing
haplotypes.
In the first set of simulation results, it can be shown how mTDT
and mTDTS hardly increased power or even reduced it with an
increase in the number of markers (window size). It is also shown
how they reduced sample reproducibility with an increase in the
number of markers as well.
Results under the assumption of a dominant genetic model for
one disease susceptibility locus and a relative risk of 2:4 are plotted
in Figure 1, which show power (recombination fraction h~0) and
locus specificity (recombination fraction hw0)o fmTDT and
mTDTS when using a data set to build the hypothesis and
compute p values (dashed lines) and when the hypothesis, i.e., a set
of haplotypes in association with the disease, is being validated by
a second data set (solid lines). The proportion of samples found in
association for nominal level a~0:05 is shown (x-axis). Sample
reproducibility, and even power, decreases with the number of
markers used: 5 (left plot), 10 (middle plot) and 20 (right plot) due
to the problem of sparse data. The same pattern can be observed
under a wide range of scenarios (see Figures S1 to S15 at http://
bios.ugr.es/2G).
Table 2. An example of parental genotype counts showing transmitted and nontransmitted haplotypes in a training and test data
sets of nuclear families and haplotypes of length 2 (4 different haplotypes: AB, AB, aB and ab).
Genotype configuration ID Transmitted haplotype Nontransmitted haplotype Counts in Training data set Counts in Test data set
1A B A B 2 53 0
2A B A b 3 02 4
3A B a B 3 5
4A B a b 7 5
5A b A B 3 73 1
6A b A b 2 12 1
7A b a B 6 7
8A b a b 5 4
9a B A B 8 9
10 aB Ab 6 8
11 aB aB 2 2
12 aB ab 3 3
13 ab AB 11 11
14 ab Ab 3 4
15 ab aB 1 2
16 ab ab 0 2
Total parental genotypes 168 168
Total trios 168=2~84 168=2~84
The total number of trios is 168 (336 parents) so that half of them (84 trios, 168 parents) were randomly assigned to the training data set and the others to the test data
set. Each row shows counts for a possible configuration (there are 16 possible configurations for haplotypes of length 2) of the transmitted (second column) and
nontransmitted (third column) haplotypes in a parental genotype.
doi:10.1371/journal.pone.0029613.t002
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population stratification and admixture of mTDT2G and
mTDT1{h, i.e. mTDT1 when used under the holdout approach.
Table 5 shows Type I error results for mTDT2G and mTDT1{h
in the presence of population stratification and admixture. Values
shown are rates of data sets in which association was found to be
statistically significant for nominal level a~0:01 and 0:05 and
different haplotype lengths (1,5,10,15 and 20, columns 4 to 8
respectively), for all configurations of pp and q values used (See
Section Materials and Methods for a detailed explanation about
the different configurations used). It can be seen that values are not
significantly different from the nominal values a, as would be
expected in a robust test for population structure and admixture.
In the third set of simulation results, we show how mTDT2G and
mTDT1{h have a good performance in sample reproducibility
and how mTDT and mTDTS also improve sample reproducibility
when using under a holdout approach too, what we called mTDTh
and mTDTS{h respectively.
In order to check sample reproducibility of mTDT2G,
mTDT1{h, mTDTh and mTDTS{h, we show p values obtained
by the tests in one data set (dashed lines) and by applying the test
on a second data set to verify whether associations found in the
first data set hold (solid lines). In the second case, the length
similarity measure was also used to plug haplotype counts from the
second data set into the model obtained from the first data set.
Results under the assumption of a recessive genetic model for
one disease susceptibility locus and a relative risk of 2:4 are plotted
in Figure 2, to compare power (recombination fraction h~0) and
locus specificity (recombination fraction 1:2,1:6,2:0,2:4 and 2:6)
among mTDTh (purple circles), mTDTS{h (blue triangles),
mTDT1{h (green squares) and mTDT2G (red diamonds) when
the null hypothesis is being validated in a second data set. The
proportion of data sets found in association for nominal level
a~0:05 is shown (x-axis). It can be observed how the holdout
approach guarantees sample reproducibility, including when used
with mTDT and mTDTS, so that differences between dashed and
solid lines are smaller compared with those shown in Figure 1.
Moreover, those algorithms with 1 df (mTDT2G and mTDT1{h)
reached the highest power. The differences seem to be more
important for smaller relative risks and two disease loci. The same
pattern can be observed under a wide range of scenarios (see
Figures S16 to S30 at http://bios.ugr.es/2G).
In general, differences among the tests increase with haplotype
length. In contrast to mTDTS, mTDT (Figure 1, solid lines) and
their holdout versions (Figure 2), power of mTDT2G in a second
data set increases with the number of markers, even when using 10
or 20 markers. mTDT2G checks a very simple hypothesis: there are
differences in transmission frequencies between the two groups of
protective and locus susceptibility haplotypes. The reason for a
higher power is that, while df do not change with the number of
markers, complex associations that cannot be captured with very
few markers will be modeled with more markers.
mTDT2G also outperforms mTDT1{h, the other test used
which has also 1 df. mTDT1{h can also be considered a 2-groups
test, but there is only one haplotype in one of the groups, and the
larger the haplotype the lower the chances of the alternative
hypothesis to be confirmed in a second sample. The hypothesis
seems to be too simplistic for models with more than one disease
locus and power hardly increases when using more than 5
markers.
Table 3. Genotype counts and their transmissions used by mTDT2G.
Nontransmitted Nontransmitted
haplotype haplotype
Transmitted g2 g1 Transmitted g2 g1
haplotype AB Ab aB ab Total haplotype AB Ab aB ab Total
g2 AB 6 25 30 3 7 40 g2 AB 6 30 24 5 5 34
g1 Ab 37 6 21 6548 g1 Ab 31 6 21 6 7 6 4 31
aB 8 6 6 2 3 17 aB 9 6 8 6 2 6 3 9
ab 11 3 1 6 0 15 ab 11 6 4 6 2 6 2 11
Total 56 39 10 15 121 Total 51 24 5 5 85
Haplotypes in rows represent those transmitted haplotypes at each genotype. Haplotypes in columns represent those nontransmitted haplotypes at each genotype.
Homozygous genotype counts (diagonal) are crossed off the tables as they are not used to compute mTDT2G: Left grid: genotype counts from the training data set
(see Table 2) used to make up groups g1 and g2 in mTDT2G: Groups are: g1~fAb,aBg, with those haplotypes with T counts larger than U counts (Ab: 48 versus 39 and
aB: 17 versus 10)a n dg2~fABg with U counts larger than T counts (56 versus 40). Right grid: genotype counts from the test data set used to compute the statistic. As
the length similarity measure is used to assign an haplotype to a group, and the two most similar haplotypes to haplotype ab belongs to group g1, ab is assigned to g1:
All the haplotypes belonging to the same group are considered of having an equivalent effect and are collapsed. Therefore, parental genotypes in the test data set with
haplotypes belonging to the same group are considered as homozygous and not used by mTDT2G (they are crossed off the table too).
doi:10.1371/journal.pone.0029613.t003
Table 4. The 2|2 table built by mTDT2G: an example.
Nontransmitted group
Transmitted
group g1: Ab, aB, ab g2: AB Total
g1: Ab, aB, ab - 31+9+11 51
g2: AB 24+5+5-3 4
Total 34 51 85
The table represents group counts, where groups are defined from the training
data set, instead of original haplotype counts (see left grid at Table 3). The
counts are obtained from the test data set (see those counts not crossed off in
Right grid at Table 3). As all the haplotypes in the same group are collapsed,
genotypes with both haplotypes in the same group are disregarded. Therefore
counts required to compute mTDT2G are: ng1g2~31z9z11~51 and
ng2g1~24z5z5~34:
doi:10.1371/journal.pone.0029613.t004
Sample Reproducibility in Multimarker TDTs
PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e29613When the number of markers decreases, the power of the tests
tends to converge, down to the situation with only 1 marker, in
which mTDTh, mTDTS{h, mTDT1{h and mTDT2G have exactly
the same results, as they default to the classic monomarker biallelic
TDT: However, when only 1 marker is used, power is very low
compared with results obtained using longer haplotypes.
Results for the fourth set of simulations are shown in Figure 3
and Figures S31 to S45 at http://bios.ugr.es/2G. These
simulations were performed as explained above for the third set
of simulations except that association rates (at recombination rate
h~0) were computed for data sets with 0%,5%,10%,15% and
20% of missing haplotypes.
As it can be seen in Figure 3 all the tets used: mTDTh,
mTDTS{h, mTDT1{h and mTDT2G are robust to missing data.
Therefore, mTDT2G still shows the highest power in data sets with
different proportions of missing data.
Results from real data sets
We tested power and locus specificity using family trio data sets
of two complex diseases: Crohn’s and MS. We also used trios of
unaffected individuals from the International Hapmap Project
(IHMP) [20] to measure specificity. We compared power and
specificity of mTDT2G with the most competitive tests considering
the wide range of scenarios in our simulations: mTDT, mTDTS
and mTDT1{h:
To show results we used sliding windows and Comparative TDT
(CTDT) [21] maps to plot averaged p values for all the windows
(i.e. haplotypes of fixed length starting at a different marker
position) covering each marker.
Figures 4, 5, and 6 respectively show p values for the MS IL2R-
affected (335 SNPs), MS EVI5-affected (38 SNPs) and MS IL7R-
affected (35 SNPs) data sets and windows of size 10. Genetic
determinants of susceptibility to MS are complex, and until
recently the only validated MS-associated polymorphic variants
were found in the major histocompatibility complex (MHC) region
[22]. Since 2007, the implementation of GWAS in combination
with high-powered patient-control cohorts has completely
changed this picture. Several GWAS and candidate gene studies
have revealed the existence of non-MHC MS susceptibility loci of
moderate genetic effect, and some of these including IL7R,
IL2RA, CLEC16A, CD226, IRF5, EVI5 and CD58 have been
validated successfully in independent studies [23–30]. However,
except for IL7R, the causal SNP of the new determined risk loci
are unknown. It is interesting to observe that the most significant
associations found by mTDT2G at the IL7R locus contained the
rs6897932 SNP (SNP number 9), the causal variant of the
association. For the IL2RA we have analyzed a wide region of the
locus including the variants that have been associated to the MS
and type 1 Diabetes (T1D). The most significant associations
found by mTDT2G are located at the IL2RA gene and 5 region of
the gene, where the maximal association have been observed in
MS and T1D studies [31].
Power and locus specificity are clearly higher in mTDT2G in
these three data sets. Moreover, locus specificity is in general
higher for mTDT2G than for mTDTS, mTDT and mTDT1{h: It
seems that the alternative hypothesis built by mTDT1{h is in
many cases too simplistic so that the more generic mTDT2G
outperforms it. See Figures S46 to S51 (sliding windows) and S52
to S57 (CTDT maps) at the supplementary website (http://bios.
ugr.es/2G) for results using different haplotype lengths 1,2,5,10,15
and 20 and all the data sets.
In agreement with the simulation results, in all cases a clear
increase is detected in the superiority of mTDT2G compared with
the other multimarker TDTs used to detect power when window
size increases. Although sample reproducibility of mTDTS and
mTDT is very high when only one marker is used, in many cases
only one marker is not enough to detect risk alleles. As an
example, in MS IL7R-affected and MS IL2R-affected, associa-
tions found by these tests using only one or two markers lack in
locus specificity and power (see Figures S46 and S47 at http://
bios.ugr.es/2G) compared with results obtained by mTDT2G using
more markers.
Discussion
mTDTS, and other tests alike, combine the segregation
differences for each of the k haplotypes in the form of summation
of squared differences. mTDT2G was derived by further relaxing
Figure 1. Association rates of mTDT and mTDTS using a second data set to test reproducibility. Results for 100 simulations of 250 family
trios as a function of the recombination rate using the dominant and one-locus genetic model and haplotypes of lengths 5 (left plot), 10 (plot in the
middle) and 20 (right plot). A nominal level of a~0:05 and a relative risk of 2:4 were used for all plots. Results for mTDT and mTDTS are plotted in
purple circles and blue triangles respectively. Dashed lines show results for the data subset (125 trios randomly chosen) used to build the model while
solid lines show results for a second data subset (the remaining 125 trios) used to test reproducibility.
doi:10.1371/journal.pone.0029613.g001
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mTDT, in order to reduce df. Thus, it does not assume any
number of haplotypes k in the population and consider the whole
effect of groups of haplotypes instead of considering the individual
effect of each haplotype. Other tests compose groups in order to
reduce df [2,7,11,12]. However, mTDT2G accomplishes this goal
to its maximum: considering only two groups, regardless of the
number of markers, means that df is always 1: With this strong
simplification we have shown that a highly significant way to
collapse haplotype into two groups is in the way mTDT2G does:
one group must represent disease susceptibility haplotypes and the
other disease protective haplotypes. Therefore, we needed to
collapse all the k haplotypes in a sample (mTDTS and mTDT
consider a unique but complex null hypothesis of no association
for exactly those k haplotypes, which is x2
k{1 under the null) into
only two groups. Moreover, for the test to be non-parametric, no
assumptions could be made to set up the groups. Basically, we had
to separate haplotypes into two groups using information from the
sample, and not any prior knowledge we may have about the
population. However, to avoid sample selection and therefore
Table 5. Type I error rates in presence of population stratification and admixture for mTDT2G and mTDT1{h.
a MAFs pp l=1 l=5 l=10 l=15 l=20
mTDT2G
0.01 0.1 0.5 0.013 0.008 0.008 0.010 0.007
0.01 0.3 0.5 0.014 0.010 0.007 0.010 0.007
0.01 0.5 0.5 0.006 0.009 0.007 0.010 0.009
0.01 0.1 0.75 0.014 0.010 0.009 0.012 0.012
0.01 0.3 0.75 0.017 0.009 0.012 0.015 0.014
0.01 0.5 0.75 0.015 0.010 0.014 0.007 0.009
0.01 0.1 0.833 0.011 0.010 0.008 0.015 0.005
0.01 0.3 0.833 0.013 0.007 0.009 0.012 0.008
0.01 0.5 0.833 0.012 0.007 0.013 0.017 0.007
0.05 0.1 0.5 0.062 0.047 0.043 0.053 0.052
0.05 0.3 0.5 0.063 0.060 0.043 0.048 0.047
0.05 0.5 0.5 0.044 0.055 0.045 0.050 0.048
0.05 0.1 0.75 0.056 0.048 0.056 0.061 0.064
0.05 0.3 0.75 0.061 0.056 0.053 0.061 0.063
0.05 0.5 0.75 0.056 0.050 0.061 0.060 0.058
0.05 0.1 0.833 0.056 0.045 0.046 0.053 0.049
0.05 0.3 0.833 0.060 0.044 0.047 0.061 0.049
0.05 0.5 0.833 0.046 0.044 0.053 0.071 0.056
mTDT1{h
0.01 0.1 0.5 0.013 0.016 0.009 0.008 0.008
0.01 0.3 0.5 0.014 0.014 0.010 0.008 0.004
0.01 0.5 0.5 0.006 0.017 0.010 0.010 0.015
0.01 0.1 0.75 0.014 0.010 0.012 0.008 0.006
0.01 0.3 0.75 0.017 0.009 0.008 0.008 0.005
0.01 0.5 0.75 0.015 0.007 0.008 0.010 0.009
0.01 0.1 0.833 0.011 0.007 0.011 0.008 0.008
0.01 0.3 0.833 0.013 0.009 0.010 0.010 0.008
0.01 0.5 0.833 0.012 0.008 0.013 0.009 0.008
0.05 0.1 0.5 0.062 0.068 0.051 0.052 0.057
0.05 0.3 0.5 0.062 0.065 0.055 0.048 0.047
0.05 0.5 0.5 0.044 0.068 0.049 0.053 0.065
0.05 0.1 0.75 0.056 0.050 0.052 0.059 0.056
0.05 0.3 0.75 0.061 0.047 0.048 0.065 0.058
0.05 0.5 0.75 0.056 0.058 0.046 0.051 0.056
0.05 0.1 0.833 0.056 0.050 0.050 0.055 0.055
0.05 0.3 0.833 0.060 0.048 0.050 0.058 0.059
0.05 0.5 0.833 0.046 0.050 0.074 0.073 0.061
Results for different minor allele frequencies (MAFs) in the second subpopulation (q) and different proportion of trios from the first subpopulation (pp), obtained by
mTDT2G (top half) and mTDT1{h (bottom half) for nominal levels a~0:01 and a~0:05 and haplotypes of length 1, 5, 10, 15 and 20 (columns 4 to 8 respectively).
doi:10.1371/journal.pone.0029613.t005
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sample than the one used to compute the statistic. mTDT2G uses
the simple holdout multisampling approach so that the sample is
divided into two equally-sized data subsets. Simulation results
showed the importance of having low df. Therefore, the fact that
mTDT2G is asymptotically x2
1 under the null hypothesis of no
linkage, regardless of the number of markers, and thus the number
of haplotypes, explains why it is on average more powerful than
mTDT and mTDTS when tested in a second data set. The more
generic hypothesis than the one built by mTDT1{h while keeping
df to 1 explains why it also outperforms mTDT1{h in simulations
and in most real data sets. This hypothesis allows considering more
than one disease variant or the situation in which the causal locus
is not sequenced but markers in LD with it, so that more than one
haplotype may be non recombinant haplotypes with the disease
variant. Therefore, mTDT2G benefits from the use of long
haplotypes to capture marker dependencies without reducing
sample reproducibility due to sparse data.
Fine-mapping association may be performed by algorithms
measuring differences in evolutionary haplotype trees [12,13,32].
Figure 2. Association rates under the holdout approach using a second data set to test reproducibility. Results for 100 simulations of
250z125 family trios as a function of the recombination rate using the recessive and one-locus genetic model and haplotypes of lengths 5 (left plot),
10 (plot in the middle) and 20 (right plot). A nominal level of a~0:05 and a relative risk of 2:4 were used for all plots. Results for mTDT{h,
mTDTS{h, mTDT1{h and mTDT2G, i.e. all tests were applied under the holdout approach, are plotted in purple circles, blue triangles, green squares
and red diamonds respectively. Dashed lines show results for a data subset of 250 trios randomly chosen while solid lines show results for a second
data subset of 125 trios used to test reproducibility of the holdout approach.
doi:10.1371/journal.pone.0029613.g002
Figure 3. Association rates for different proportions of missing haplotypes. Results for 100 simulations of 250z125 family trios as a
function of the proportion of missing haplotypes using the additive and one-locus genetic model and haplotypes of lengths 5 (left plot), 10 (plot in
the middle) and 20 (right plot). A nominal level of a~0:05 and a relative risk of 2:4 were used for all plots. Results for mTDT{h, mTDTS{h,
mTDT1{h and mTDT2G, i.e. all tests were applied under the holdout approach, are plotted in purple circles, blue triangles, green squares and red
diamonds respectively.
doi:10.1371/journal.pone.0029613.g003
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are used as starting point, instead of case versus control subsamples
[12,32], or transmitted versus nontransmitted subsamples [13].
Moreover, using the holdout approach seems to be an interesting
solution that has also been applied to other group-based measures,
such as mTDT1 or to the more classic mTDT and mTDTS: In
contrast to the Bonferroni correction, which over-corrects the
measure by performing a linear correction of p values, or other
more complex and low accurate solutions, the holdout approach in
mTDT1{h and mTDT2G, guarantees an asymptotically x2
1 null
distribution. Moreover, as the number of markers increases, validity
of mTDT and mTDTS decreases and the holdout approach is a
computationally feasible solution for genome-wide scan, compared
withhighlytime-consuming simulation tests. Therefore,mTDT2G is
a very competitive test to perform genome-wide scan because of its
high performance in power, locus specificity, sample reproducibility
and low computational cost.
In conclusion, we expect that mTDT2G will prove useful in
detecting association for any complex disease in which relative
risk due to a disease locus can be low, and power needs to be
maximized by using several markers at a time, without results
being affected by sparse data. We also expect the two
haplotype groups g1 and g2 defined by mTDT2G may also be
used as the starting point for any method developed to perform
haplotype fine mapping. Moreover, the test may be used as a
first loci-selection step in the process of building more accurate
genetic models to predict individual predisposition to complex
diseases.
Materials and Methods
In this section we explain which other tests were used to
compare the performance of mTDT2G, as well as the simulation
and real data set studies performed for the comparisons.
Figure 4. Sliding window maps for the IL2R-affected data set. Window size is 10: TDTs used were mTDT2G (red diamonds), mTDT1{h (green
squares), mTDT{h (purple circles) and mTDTS{h (blue triangles).
doi:10.1371/journal.pone.0029613.g004
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http://bios.ugr.es/2G, where Figures S1–S57, data sets, the
software used to obtain the samples upon which the simulations
were performed (scripts for linux and software in c++) and 2G, the
software used to implement the method, are available.
Comparative studies
We compared the performance in the state-of-the-art mTDT,
mTDTS and mTDT1{h with mTDT2G in both simulations and
real data sets.
We chose these tests after comparing power and locus specificity
among different state-of-the-art multimarker TDTs: mTDT,
mTDTS, mTDTLC, mTDTE and mTDTSR (data not shown).
mTDT and mTDTS showed much higher power and locus
specificity than the others and have a low computational complexity
so that they are a practical choice for genome-wide scan.
We performed four different simulation studies: (1) We tested
sample reproducibility in mTDT and mTDTS, and observed a lack
of it which increased with the number of markers. (2) We tested
robustness to population stratification of mTDT2G and mTDT1{h:
(3) We chose the holdout approach for allthetests tomake sure power
will be kept when testing on a second data set and therefore we
compared power and locus specificity of mTDT2G, mTDT1{h,
mTDTS{h (the holdout version of mTDTS)a n dmTDTh (the
holdout version of mTDT), in a first data set and in a second data
set to measure sample reproducibility. (4) We tested robustness of
mTDT2G, mTDT1{h, mTDTS{h and mTDTh to different propor-
tions of missing haplotypes.
After the simulation studies, we used real data sets and the
holdout approach in order to guarantee that the results would be
reproducible in a different independent data set, for all the
multimarker TDTs used in the simulations.
Figure 5. Sliding window maps for the EVI5-affected data set. Window size is 10: TDTs used were mTDT2G (red diamonds), mTDT1{h (green
squares), mTDT{h (purple circles) and mTDTS{h (blue triangles).
doi:10.1371/journal.pone.0029613.g005
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Simulation analyses were performed using haplotype data sets of
family trios. Simulations were similar to those used in several
works [2,5,32], with the intention of evaluating both robustness to
stratification population and sensitivity to a disease susceptibility
locus. However we also added simulations to test locus specificity
and sample reproducibility, as it above explained.
As one of our main goals was to have a useful test to perform
genome-wide association filtering, computational complexity was a
main issue and a linear relationship between computational
complexity and the number of SNPs was highly desirable.
Therefore, we applied the tests in a very feasible way in which
only consecutive or overlapping clusters of SNPs (known as sliding
windows) were tested together.
In order to simulate a cluster, as suggested by [33], we assumed
that recombination rates between all markers tested were very low,
which is equivalent to assuming they belong to the same low
recombination block [34]. The recombination fraction within blocks
(hB) for a common population with exponential growing, such as an
African population,hasbeenestimated tobe 0:000088 [35], and this
is the value used in this work. By testing only consecutive SNPs at
high LD we chose a method that is easily adaptable for use with
genome-wide genotype data sets by using sliding windows. A disease
susceptibility locus was placed at one extreme of the low
recombination block. In those tests where the distribution under
the null hypothesis is not known, statistical significance levels were
obtained by using a permutation procedure known as the Monte
Carlo test [16]. To investigate the effect of haplotype width,
simulations were performed over different haplotype lengths within
the low recombination block: 1,5,10,15 and 20:
We also altered the way disease mutations were introduced, and
decided to use the more realistic and now standard coalescent
Figure 6. Sliding window maps for the IL7R-affected data set. Window size is 10: TDTs used were mTDT2G (red diamonds), mTDT1{h (green
squares), mTDT{h (purple circles) and mTDTS{h (blue triangles).
doi:10.1371/journal.pone.0029613.g006
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chromosome with the disease causing mutation, or the improve-
ment of using two ancestral chromosomes [5], a more realistic
simulation of complex disease inheritance was used, in which the
number of disease ancestral chromosomes can change according
to the coalescent model, as any other gene does. We used MS
sample to draw the populations [36].
Populations were drawn using msHOT [37], a program for
generating samples based on the coalescent model that incorpo-
rates recombination. The samples for all the populations were
obtained using trioSampling, a computer program we developed and
which is available at the supplementary website.
Specific configurations required to test robustness, power and
locus specificity are explained in the next subsections. A more
detailed explanation of the simulations performed can be accessed
at the supplementary website.
Robustness to population stratification. Type I error
rates under population stratification and admixture were estimated
based upon 1000 replications of the simulations here described.
The data sets obtained from the populations were composed of
500 nuclear families with only one child (affected). In order to
check whether mTDT2G and mTDT1{h were robust to population
stratification, we checked Type I errors in samples with affected
individuals, for regions not in linkage with the disease locus
(recombination fraction from the markers to the disease locus
h~0:5), considering the simulation design of [2]. Therefore each
stratified population drawn consisted of two sub-populations [2],
with 500pp nuclear families from the first population and
500(1{pp) nuclear families from the second one, where pp is
the proportion of trios chosen from the first subpopulation.
Populations were generated as described by [2] and [5], with
founder haplotypes randomly having alleles at every marker
independently. MAFs of 0:5 for the first subpopulation were
assumed, while MAFs for the second subpopulation q were
parameterizable, with q[f0:1,0:3,0:5g. Frequencies for the disease
allele at disease susceptibility locus (pD) were 0:2 and 0:3 for the
first and second subpopulation respectively. Families were
randomly sampled by choosing haplotypes with the disease
mutation with probability pD for the parents and randomly
choosing the haplotypes transmitted to children considering
recombinations. As it was done by [2] and [5], we also varied
pp to have values f1=2,1=4,1=6g. Therefore, by varying pp and q,
nine different scenarios where considered in order to test
robustness. The samples obtained from each population were
composed of 500 nuclear families with only one child.
Power and locus specificity. Association rates were
estimated based upon 100 replications of the simulations here
described. The data sets obtained from the populations were
composed of 250 nuclear families with only one child (affected).
When only one disease susceptibility locus was used, it was placed at
one extreme of the low recombination block the markers belonged
to. When two disease loci were used, the first was placed in the same
way, whilethe second was placed at a position with h~0:1 from that
block, in order to model a second disease locus not in linkage with
the tested markers [5]. The power of the tests was analyzed under
three genetic models for one disease susceptibility locus: additive,
dominant and recessive, and six genetic models for two disease
susceptibility loci: additive, dom-and-dom, rec-or-rec, dom-or-dom,
threshold and modified [5]. Different relative genotype risks RR
were also used: 1:2,1:6,2:0,2:4 and 2:6: RR is defined as
Pr(diseasejDD)=Pr(diseasejdd), with d being the normal allele
and D the disease allele for simulations with only one disease locus,
and as Pr(diseasejDDEE)=Pr(diseasejddee) for simulations of two
diseaseloci, with e being the normal allele at the second diseaselocus
and E the disease allele at that locus [5]. Relative risks for all other
genotypes were computed based on RR [5,38] (see Table S1 on the
supplementary website). To simulate a complex disease, disease loci
were chosen among markers with MAFs in the intervals ½0:2{0:4 :
Simulations for power (sensitivity), i.e., assuming no recombi-
nation between the disease susceptibility locus and the markers
tested, were similar to those used in several studies assuming one
founder disease haplotype [2,5,32], except that SNPs tested
together were assumed to be in high LD, i.e., they belong to the
same low-recombination block [34].
To test locus specificity, we added six other different
recombination fractions (h) from the markers to the disease
susceptibility locus, to the perfect LD (no recombination) used to
test power: 0:00005, 0:0001, 0:00015 and 0:0002:
Sample reproducibility. To check sample reproducibility,
for each data set used as a first step, a second independent data set
from the same population with 125 family trios as well was used to
compute p values. The length similarity measure was used by all
the tests to plug the second data set into the model learned from
the first data set. Association rates using 100 simulations were used
to evaluate results.
Missing data. To check whether the tests were robust to
missing data, we randomly chose a marker and a parent and
deleted the parental genotype at that marker until reaching the
desired proportion of missing data (5%,10%,15% and 20%).
Real data
Sample reproducibility. Nine data sets of genotypes from
trio families were used; one with offspring having Crohn’s disease,
the other nine with offspring having MS disease. The Crohn
affected data set (IBD5-affected) is a publicly available set that was
originally used by [39]. It consists of the genotype data of 103
SNPs typed in 129 trios with offspring having Crohn’s disease
[34]. The phenotype is the presence/absence of Crohn disease.
The SNPs span across 500 kilobases at the IBD5/SLC22A4 locus
(5q31), and the region contains 11 known genes. For MS disease,
genotype information was obtained from a GWAS performed by
the International Multiple Sclerosis Genetic Consortium. A DNA
microarray (GeneChip Human Mapping 500 K Array Set,
Affymetrix) was used by that study to examine 334,923 common
genetic variants in 931 family trios, consisting of a patient with MS
and both parents [23]. Nine regions corresponding to risk loci for
MS as previously determined in well powered studies [23,29] were
chosen. Table 6 details information about the MS data sets.
Results shown are meant to be highly valid and sample
reproducible. Therefore, we chose the holdout approach in all
the tests used. This way we increase the chances of finding similar
power and locus specificity results if a second data set from the
same population were to be used.
Data sets to test specificity. To check specificity in real
data, for each data set with affected offspring we fabricated data
sets for healthy trios, using data publicly available on the IHMP
website [20], comprised of genotype data for 30 family trios
(HapMap Phase II) typed in a population of Utah residents with
ancestry from northern and western Europe (CEPH).
In the particular case of the IBD5-affected data set, most SNPs
were not genotyped by the IHMP. As a solution, the IBD5-
unaffected data set was composed by choosing the CEPH
genotypes of only 656 consecutive SNPs (positions 276117 to
890934) out of 247,632 SNPs from chromosome 5, to correspond
to the same region as in the IBD5-affected data set. It has to be
noted that SNP density in the CEPH data set is about 6 times
higher than that in the IBD5-affected data set. To prevent
differences in densities to bias results, we chose only one SNP for
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only 110 SNPs were selected to create the IBD5-unaffected data
set. IBD5-affected and IBD5-unaffected data sets are both
available at the supplementary website. As it was done with
disease data sets, data were split in order to test specificity in a
second sample.
All unaffected data sets used to test specificity in MS samples are
also available at the supplementary website.
Genome-wide exploration. In general, for a multimarker
TDT to be used in data sets with genotypes spanning many bases,
some techniques must be used to divide the region into smaller
sequences so that individual tests can be applied to each sequence
within a feasible computation time. In order to use a TDT to
perform genome-wide pre-filtering, we only tested together SNPs
in strong LD. Strategies to perform genome-wide searches using
SNPs not in LD are very time consuming if they are exhaustive.
For example, with only 2 markers tested together, computational
time is quadratic to the number of markers. Thus, this is usually
the maximum number of SNPs tested together in TDT or case/
control studies that consider SNPs not in LD [40]. Therefore, we
only considered consecutive sequences of SNPs to be tested
together. Different haplotype lengths w[f1,2,5,10,15,20g were
used to investigate the effects upon power. To reduce random
errors, we used sliding windows [34] of width w and an offset of 1
SNP. Before these calculations, we investigated dividing the whole
chromosome into blocks of low recombination by using several
algorithms proposed in the literature [41]. However, as blocks
turned out to be very different depending upon the algorithm used
(results not shown), we decided not to perform this division to
avoid biased results.
Unknown haplotypes. If genotypes, instead of haplotypes,
were the only information available, the phase for each family and
marker was inferred using information from the family [5,42].
Phase for those markers that remained unsolved, was estimated by
using the E-M algorithm under the restriction of family
information [2,5,43]. Other algorithms for phase resolution are
known to be more accurate but at a high computational cost, such
as Phase [44], an algorithm that uses Gibbs sampling for phase
reconstruction of each individual.
For mTDT2G, each data set of genotypes was divides into two
equal-size data subsets, from which haplotypes were obtained.
Comparative TDT maps. For a quick visual comparison of
power and specificity between these different measures, we also
used CTDT maps [21] for all the data sets and all the window
sizes used. These maps are colored only in those regions found in
association. Results from each TDT are plotted in a different pair
of consecutive rows. The first row in a pair (white color
background) shows results from the affected data sets at every
marker to test power. The second row in the pair (gray
background) shows results from the unaffected data sets to test
specificity at every marker. All rows in a map have the same
length, as it represents the number of markers in the sample. The
height of a row represents the association level. If height is 0 when
used with affected offspring, it means that the p value at that
marker is larger than 0:01, and the test is considered powerless to
detect association to that SNP. When used with samples of
unaffected offspring, height must be 0 except in the situation of a
protective locus.
Supporting Information
Text S1 An Appendix which shows that mTDT2G follows
a x2
1 distribution under the null hypoyhesis of no linkage.
(PDF)
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